- The thymus is a lobular gland located under the breastbone near the thyroid gland that plays a role in immune function. With age, the thymus is replaced by fat and connective tissue.
- According to legend, glandular or organotherapy, which refers to the use of animal tissues or cell preparations to improve physiologic functioning and support the natural healing process, first gained popularity in the early to mid 1900s. The idea of homeopathic glandular therapy was first introduced almost 200 years ago. Thymus extracts for nutritional supplements usually come from young calves (bovine). Bovine thymus extracts are found in capsules and tablets as dietary supplements.
- Thymus extract is commonly used to stimulate the immune system and to treat bone marrow failure, autoimmune disorders, chronic skin diseases, recurrent viral and bacterial infections, hepatitis, allergies, chemotherapy side effects, and cancer. Most basic and clinical research involving oral and injectable thymus extract has been conducted in Europe.
- Studies in humans suggest promising results in terms of allergies, asthma, cancer, chemotherapeutic side effects, cardiomyopathy (weakening of the heart muscle), chronic obstructive pulmonary disease, HIV/AIDS, liver disease, respiratory tract infections, systemic lupus erythematosus, and tuberculosis and to stimulate the immune system However, not all study results agree, and more well designed studies are still needed in many fields.
← Back to Monographs
ingredients
Thymus extract
Contents
- Akhmedov RM, Ochilov UB, Mirkhodzhaev IA, et al. [Prevention and treatment of postoperative complications of hepatic echinococcosis]. Med Parazitol (Mosk) 2003;(2):18-21.
View Abstract - Aleksandrovskii IuA, Chekhonin VP. [Clinical and immunological studies in borderline mental disorders: problems and solutions]. Vestn Ross Akad.Med Nauk 1999;(7):12-15.
View Abstract - Arutiunian VM, Grigorian EG. [Effectiveness of using immunomodulators in combined treatment of patients with chronic gastritis and ulcer disease]. Klin Med (Mosk) 2003;81(5):33-35.
View Abstract - Chien RN, Liaw YF. Thymalfasin for the treatment of chronic hepatitis B. Expert Rev Anti Infect Ther 2004;2(1):9-16.
View Abstract - Christ HW. [Immunomodulating therapy of psoriasis vulgaris]. Med Klin (Munich) 10-15-1999;94 Suppl 3:90-92.
View Abstract - Jablonowska E, Tchorzewski H, Lewkowicz P, et al. Reactive oxygen intermediates and serum antioxidative system in patients with chronic C hepatitis treated with IFN-alpha and thymus factor X. Arch Immunol Ther Exp (Warsz.) 2005;53(6):529-533.
View Abstract - Kevorkov NN, Gorovits GA, Bakhmet'ev SA. [Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes]. Ter Arkh 2002;74(3):55-58.
View Abstract - Liberati AM, Ballatori E, Fizzotti M, et al. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission. Cancer Immunol Immunother 1988;26(1):87-93.
View Abstract - Mustacchi G, Pavesi L, Milani S, et al. High-dose folinic acid (FA) and fluorouracil (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer: results of a randomized multicenter clinical trial. Anticancer Res 1994;14(2B):617-619.
View Abstract - Nazarov IP, Popov AA, Protopopov BV, et al. [Ways of correcting immunodeficiency at different stages of burns with the aim of prevention and treatment of sepsis]. Anesteziol Reanimatol 1999;(1):63-68.
View Abstract - Popiela T, Kulig J, Klek S, et al. Enzyme therapy in patients with advanced colorectal cancer. Przegl Lek 2000;57 Suppl 5:138-139.
View Abstract - Raymond RS, Fallon MB, Abrams GA. Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 11-15-1998;129(10):797-800.
View Abstract - Romeo F, Arcoria D, Palmisano L, et al. Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial. Arzneimittelforschung 1985;35(8):1317-1322.
View Abstract - Salvati F, Pallotta G, Antilli A, et al. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial]. G Ital Chemioter 1984;31(1-2):185-189.
View Abstract - Sanchiz F, Milla A. A randomised study comparing granulocyte-colony stimulating factor (G-CSF) with G-CSF plus thymostimulin in the treatment of haematological toxicity in patients with advanced breast cancer after high dose mitoxantrone therapy. Eur J Cancer 1996;32A(1):52-56.
View Abstract
Disclaimer: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.
